Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: A case report and review of the literature

CelesteAnn T. Bremer, Ashton Lastrapes, Arnold B. Alper, Raja Mudad

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Chronic myelogenous leukemia (CML), hepatitis C, and interferon alpha (IFNα) have all been associated with renal dysfunction. In this paper we present a patient with the diagnosis of nephrotic syndrome and a known history of hepatitis C who received IFNα therapy for newly diagnosed CML. The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with IFNα. There have also been two cases of patients with hepatitis C associated with focal segmental glomerulosclerosis. Despite the underlying hepatitis C, this case represents renal abnormalities consistent with IFNα therapy for CML.

Original languageEnglish (US)
Pages (from-to)262-264
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume26
Issue number3
DOIs
StatePublished - Jun 2003
Externally publishedYes

Fingerprint

Focal Segmental Glomerulosclerosis
Hepatitis C
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interferon-alpha
Kidney
Nephrotic Syndrome
Biopsy
Therapeutics

Keywords

  • Chronic myelogenous leukemia
  • Focal segmental glomerulosclerosis
  • Hepatitis C
  • Interferon alpha
  • Nephrotic syndrome

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia : A case report and review of the literature. / Bremer, CelesteAnn T.; Lastrapes, Ashton; Alper, Arnold B.; Mudad, Raja.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 26, No. 3, 06.2003, p. 262-264.

Research output: Contribution to journalArticle

@article{90ed5c5894044b4eb60a18ed43c7e541,
title = "Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: A case report and review of the literature",
abstract = "Chronic myelogenous leukemia (CML), hepatitis C, and interferon alpha (IFNα) have all been associated with renal dysfunction. In this paper we present a patient with the diagnosis of nephrotic syndrome and a known history of hepatitis C who received IFNα therapy for newly diagnosed CML. The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with IFNα. There have also been two cases of patients with hepatitis C associated with focal segmental glomerulosclerosis. Despite the underlying hepatitis C, this case represents renal abnormalities consistent with IFNα therapy for CML.",
keywords = "Chronic myelogenous leukemia, Focal segmental glomerulosclerosis, Hepatitis C, Interferon alpha, Nephrotic syndrome",
author = "Bremer, {CelesteAnn T.} and Ashton Lastrapes and Alper, {Arnold B.} and Raja Mudad",
year = "2003",
month = "6",
doi = "10.1097/00000421-200306000-00011",
language = "English (US)",
volume = "26",
pages = "262--264",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia

T2 - A case report and review of the literature

AU - Bremer, CelesteAnn T.

AU - Lastrapes, Ashton

AU - Alper, Arnold B.

AU - Mudad, Raja

PY - 2003/6

Y1 - 2003/6

N2 - Chronic myelogenous leukemia (CML), hepatitis C, and interferon alpha (IFNα) have all been associated with renal dysfunction. In this paper we present a patient with the diagnosis of nephrotic syndrome and a known history of hepatitis C who received IFNα therapy for newly diagnosed CML. The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with IFNα. There have also been two cases of patients with hepatitis C associated with focal segmental glomerulosclerosis. Despite the underlying hepatitis C, this case represents renal abnormalities consistent with IFNα therapy for CML.

AB - Chronic myelogenous leukemia (CML), hepatitis C, and interferon alpha (IFNα) have all been associated with renal dysfunction. In this paper we present a patient with the diagnosis of nephrotic syndrome and a known history of hepatitis C who received IFNα therapy for newly diagnosed CML. The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with IFNα. There have also been two cases of patients with hepatitis C associated with focal segmental glomerulosclerosis. Despite the underlying hepatitis C, this case represents renal abnormalities consistent with IFNα therapy for CML.

KW - Chronic myelogenous leukemia

KW - Focal segmental glomerulosclerosis

KW - Hepatitis C

KW - Interferon alpha

KW - Nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=0037841391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037841391&partnerID=8YFLogxK

U2 - 10.1097/00000421-200306000-00011

DO - 10.1097/00000421-200306000-00011

M3 - Article

C2 - 12796597

AN - SCOPUS:0037841391

VL - 26

SP - 262

EP - 264

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 3

ER -